Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Oct 26, 2010


CGC Genetics this week introduced a microarray panel to complement clinical diagnosis of cases where there is evidence of syndromic and nonsyndromic congenital deafness.

According to the firm, the test identifies the most frequent genetic alterations, which include 312 point mutations in 32 genes, involved in congenital hearing loss.

CGC's assay is run on the Illumina BeadXpress system.

EMD Millipore this week introduced a kit for bisulfite conversion, the first step in mapping the differences in genomic DNA methylation patterns.

The CpGenome Turbo Kit converts unmethylated cytosines to uracil in 90 minutes, which EMD Millipore claims is twice as fast as commonly used bisulfite kits and reagents.

The kit features a conversion reagent that reduces incubation times while retaining high efficiency, converting almost all unmethylated cytosines to uracil, according to the firm.

The resulting modified DNA is ready for epigenetic mapping by sequencing, microarray hybridization, or quantitative PCR.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.